汇宇制药: 第二届董事会独立董事专门会议第四次会议决议

Core Points - The meeting of the independent directors of Sichuan Huiyu Pharmaceutical Co., Ltd. was held on August 28, 2025, via telecommunication, with all three independent directors present [1][2] - The independent directors unanimously approved the proposal to increase the estimated amount of daily related party transactions for 2025, ensuring that the pricing is fair and reasonable, and does not harm the interests of the company or its shareholders [1][2] Summary by Sections - Meeting Details - The second special meeting of the independent directors was convened with all three independent directors present, and the procedures complied with relevant laws and regulations [1] - Decision on Related Party Transactions - The proposal to increase the estimated amount of daily related party transactions for 2025 was approved, aimed at meeting the needs of daily operations [1] - The pricing for these transactions is based on fairness and reasonableness, ensuring no adverse impact on the company's financial status or independence [1][2] - The decision was made with a unanimous vote of 3 in favor, with no votes against or abstentions [2]